Secor Capital Advisors’s Natus Medical Inc NTUS Stock Holding History

Secor Capital Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-54,388	Closed	-$1.38M	–	323
2019 Q1	$1.38M	Buy	+54,388	New	+$1.62M	0.28%	108
2017 Q2	–	Sell	-41,569	Closed	-$1.63M	–	607
2017 Q1	$1.63M	Sell	41,569 -55,570	-57%	-$2.08M	0.18%	178
2016 Q4	$3.38M	Sell	97,139 -16,810	-15%	-$660K	0.41%	61
2016 Q3	$4.48M	Buy	+113,949	New	+$4.54M	0.49%	50
2016 Q2	–	Sell	-11,753	Closed	-$452K	–	745
2016 Q1	$452K	Buy	+11,753	New	+$438K	0.06%	347
2015 Q2	–	Sell	-8,230	Closed	-$325K	–	581
2015 Q1	$325K	Sell	8,230 -15,614	-65%	-$576K	0.13%	290
2014 Q4	$859K	Buy	+23,844	New	+$801K	0.36%	83
2014 Q3	–	Sell	-11,483	Closed	-$289K	–	395
2014 Q2	$289K	Buy	+11,483	New	+$284K	0.15%	202

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Secor Capital Advisors's NTUS Position: Q2 2019 in Review

Secor Capital Advisors sold out of Natus Medical Inc (NTUS) in Q2 2019, closing a stake of 54,388 shares — an estimated $1.38M sold.

Secor Capital Advisors first reported a position in NTUS in Q2 2014 and held it in 8 quarters. The position peaked at $4.48M in Q3 2016. 175 funds tracked by Wall St. Rank hold NTUS as of Q2 2019.

Secor Capital Advisors reported no remaining Natus Medical Inc position as of Q2 2019 after selling out during the quarter.
Secor Capital Advisors sold 54,388 Natus Medical Inc shares in Q2 2019, an estimated $1.38M.
Secor Capital Advisors first reported a position in Natus Medical Inc in Q2 2014 and held it in 8 quarters.
Secor Capital Advisors's Natus Medical Inc position peaked at $4.48M in Q3 2016.
175 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2019.

Based on Secor Capital Advisors's 13F filing for Q2 2019.